Prevalence, Virulence Profiles, and Clinical Significance of Shiga Toxin-Negative Variants of Enterohemorrhagic Escherichia coli O157 Infection in Humans
Open Access
- 1 July 2007
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 45 (1) , 39-45
Abstract
Background. Escherichia coli O157, of the H7 clone, exists in humans and in the environment as Shiga toxin (Stx)–positive and Stx-negative variants.Keywords
This publication has 33 references indexed in Scilit:
- Molecular and phenotypic profiling of sorbitol-fermenting Escherichia coli O157:H− human isolates from FinlandClinical Microbiology and Infection, 2006
- Isolation and characteristics of sorbitol-fermenting Escherichia coli O157 strains from cattleMicrobes and Infection, 2006
- Sorbitol-fermenting Shiga toxin-producing Escherichia coli O157: indications for an animal reservoirEpidemiology and Infection, 2005
- Enterohaemorrhagic Escherichia coli in human medicineInternational Journal of Medical Microbiology, 2005
- Clinical Course and the Role of Shiga Toxin–ProducingEscherichia coliInfection in the Hemolytic‐Uremic Syndrome in Pediatric Patients, 1997–2000, in Germany and Austria: A Prospective StudyThe Journal of Infectious Diseases, 2002
- CORRESPONDENCEJournal of Medical Microbiology, 2002
- Escherichia coliHarboring Shiga Toxin 2 Gene Variants: Frequency and Association with Clinical SymptomsThe Journal of Infectious Diseases, 2002
- Shiga toxinsToxicon, 2001
- Parallel evolution of virulence in pathogenic Escherichia coliNature, 2000
- A Large Outbreak of Hemolytic Uremic Syndrome Caused by an Unusual Sorbitol‐Fermenting Strain ofEscherichia coliO157:H−The Journal of Infectious Diseases, 1999